English HTA Finally Greenlights Conditional Funding for MSD’s Welireg

 
• By Francesca Bruce

MSD welcomes the decision but says the drug should have gone through NICE’s Highly Specialized Technologies route that allows more flexibility regarding uncertainty around rare disease drugs.

POUND PILL
Despite positive recommendations, MSD maintains Welireg should have been subject to NICE's appraisal process for very rare disease treatments • Source: Shutterstock

More from United Kingdom

More from Europe